date
sequencespecif
pcr
common
approach
viru
identif
quantif
diagnost
laboratori
highli
sensit
rapid
cost
effect
howev
specif
pcr
requir
prior
knowledg
viru
sequenc
separ
assay
need
design
individu
viru
viru
type
recent
highthroughput
next
gener
sequenc
ng
technolog
enabl
metagenomicbas
identif
virus
sequenc
random
fragment
genom
present
clinic
environment
sampl
viral
metagenom
virussequ
independ
potenti
viru
cultiv
uncultiv
known
novel
readili
detect
method
appli
type
viru
genom
includ
singlestrand
dna
rna
sever
research
studi
use
technolog
recent
year
explor
breadth
virom
divers
biolog
environment
sampl
includ
human
anim
fece
blood
anim
human
tissu
human
respiratori
tract
secret
highlight
valid
approach
detect
rare
novel
virus
despit
numer
promis
attempt
appli
metagenom
virolog
direct
sequenc
nucleic
acid
obtain
biolog
sampl
result
high
background
genet
materi
mainli
deriv
host
bacteria
hamper
detect
virus
sampl
type
greatli
influenc
composit
sequenc
read
due
complex
clinic
materi
sampl
prepar
viru
enrich
method
need
specif
adapt
common
step
sampl
prepar
unbias
metagenom
sequenc
viru
enrich
extract
nucleic
acid
revers
transcript
unbias
amplif
variou
viru
enrich
method
clinic
sampl
suggest
commonli
employ
method
includ
filtrat
ultracentrifug
nucleas
treatment
method
reli
small
size
virus
stabil
capsid
sever
approach
viru
genom
amplif
exist
multipl
displac
amplif
mda
often
use
whole
genom
amplif
eg
vidisca
method
viru
discoveri
linkeramplifi
shotgun
librari
lasl
appli
viru
sequenc
marin
water
sampl
anchor
random
pcr
approach
use
studi
frequent
use
describ
detail
previou
studi
test
variou
condit
method
viru
enrich
nucleic
acid
extract
unbias
amplif
goal
creat
sensit
robust
workflow
metagenom
sequenc
clinic
sampl
viru
diagnost
spike
sever
viru
type
plasma
healthi
donor
cover
differ
class
virus
small
nonenvelop
dna
human
adenoviru
larg
envelop
dna
human
herpesviru
human
herpesviru
small
nonenvelop
rna
viru
polioviru
envelop
rna
viru
influenzaviru
addit
file
tabl
valid
approach
use
highli
multiplex
viral
pathogen
reagent
contain
differ
virus
final
experi
differ
ratio
spike
virus
show
good
correl
rel
number
sequenc
read
viru
input
human
adenoviru
human
polioviru
strain
lsa
human
herpesviru
atcc
vr
ad
propag
cell
human
fetal
lung
fibroblast
obtain
european
collect
cell
cultur
salisburi
uk
virus
cultiv
day
cell
sonic
centrifug
min
rpm
supernat
harvest
filter
human
herpesviru
propag
cell
marmoset
blymphoblastoid
cell
line
centrifug
min
rpm
supernat
harvest
filter
influenzaviru
propag
cell
human
alveolar
basal
epitheli
cell
influenzaviru
mdck
cell
canin
kidney
epitheli
cell
day
supernat
centrifug
min
rpm
aliquot
store
viral
load
spike
sampl
amplicon
concentr
random
amplif
determin
qpcr
describ
previous
polioviru
adenoviru
influenzaviru
cdc
protocol
realtim
rtpcr
swine
influenza
april
realtim
pcr
perform
describ
previous
modifi
primer
cttctcagtccagcgcgttt
cagtggtccccctccctaga
modifi
probe
famcgtaagccagacagcagccaattgtcagtamra
reaction
perform
realtim
pcr
system
life
technologiesthermo
fisher
scientif
waltham
taqman
rnatoct
kit
onemicrolit
templat
extract
eluat
amplif
reaction
respect
use
master
mix
primer
probe
total
volum
sampl
test
duplic
follow
cycl
condit
min
min
cycl
min
experi
use
differ
ratio
viru
input
viru
stock
quantifi
digit
pcr
use
quantstudio
digit
pcr
system
life
technologiesthermo
fisher
scientif
allow
absolut
quantif
without
need
standard
reaction
perform
final
volum
quantstudio
digit
pcr
master
mix
primer
probe
primer
probe
use
qpcr
assay
describ
templat
dilut
necessari
optim
digit
pcr
readout
rna
viru
quantif
reaction
addit
contain
taqman
rt
enzym
mix
initi
revers
transcript
step
min
follow
min
cycl
condit
cycl
min
min
readout
quantstudio
digit
pcr
instrument
raw
data
import
quantstudio
analysissuit
cloud
softwar
version
calcul
absolut
copi
number
human
clinic
sampl
obtain
healthi
blood
donor
zurich
blood
donor
servic
schlieren
switzerland
diagnost
sampl
test
neg
polioviru
influenzaviru
adenoviru
store
sampl
centrifug
rpm
min
heraeu
multifug
r
thermo
fisher
scientif
spike
virus
achiev
quantit
pcr
threshold
cycl
ct
valu
consid
high
posit
sampl
diagnost
test
virus
filtrat
done
use
pe
filter
tpp
trasadingen
switzerland
freezethaw
cycl
applic
perform
freez
sampl
nucleas
treatment
dnase
rnase
perform
previous
describ
reagent
volum
scale
clinic
sampl
briefli
nucleas
mix
contain
dnase
mgml
roch
basel
switzerland
rnasea
mgml
qiagen
hilden
germani
nucleas
buffer
mm
trishcl
mm
nacl
mm
mm
ph
pb
water
ad
reaction
incub
h
thermoshak
rpm
sampl
treat
proteas
mgml
qiagen
min
remov
nucleas
activ
qiaamp
viral
rna
mini
kit
qiagen
purelink
viral
rnadna
mini
kit
life
technologiesthermo
fisher
scientif
nuclisen
easymag
system
craponn
franc
use
accord
manufactur
instruct
two
input
volum
spike
plasma
test
elut
achiev
high
sampl
concentr
larg
start
volum
load
extract
column
multipl
step
accord
manufactur
instruct
necessari
first
protocol
unbias
nucleic
acid
amplif
process
rna
dna
virus
combin
singl
reaction
call
combin
protocol
chang
protocol
includ
separ
amplif
step
rna
dna
replac
polymeras
dna
polymeras
larg
klenow
fragment
neb
biolab
ipswich
call
separ
protocol
direct
comparison
klenow
fragment
use
workflow
rna
workflow
cdna
gener
revers
transcript
primer
contain
random
octam
link
anchor
sequenc
atcgtcgtcgtaggctgctcnnnnnnnn
five
microlit
eluat
use
templat
total
volum
random
primer
mm
dntp
first
strand
buffer
mm
dtt
superscript
iii
invitrogenlif
technolog
templat
random
primer
heat
min
follow
revers
transcript
min
inactiv
min
prior
second
strand
synthesi
cdna
denatur
min
cool
min
second
strand
synthes
dna
polymeras
klenow
neb
buffer
final
volum
min
follow
enzym
inactiv
step
min
addit
step
second
strand
synthesi
use
initi
combin
protocol
omit
dna
workflow
start
denatur
step
min
perform
random
primer
use
rna
workflow
prior
second
strand
synthesi
second
strand
synthesi
perform
use
condit
describ
rna
workflow
amplif
anchor
primer
amplitaq
gold
thermo
fisher
scientif
perform
previous
describ
separ
rna
dna
workflow
qualiti
size
anchor
pcr
product
assess
capillari
gel
electrophoresi
fragment
analyz
advanc
analyt
ame
ia
pcr
product
quantifi
picogreen
invitrogenthermo
fisher
scientif
dilut
dna
rna
prepar
pool
equal
concentr
construct
sequenc
librari
nexteraxt
protocol
illumina
san
diego
ca
individu
sampl
dual
index
librari
prepar
pool
sequenc
librari
sequenc
miseq
illumina
cycl
version
reagent
fastq
workflow
sampl
demultiplex
use
miseq
report
raw
sequenc
read
avail
zenodo
repositori
read
process
dedic
bioinformat
pipelin
virmet
version
develop
laboratori
http
briefli
read
qualityfilt
remov
low
qualiti
base
averag
phred
score
read
shorter
bp
read
low
entropi
ie
consist
mainli
repeat
read
pass
qualiti
filter
clean
nonvir
read
align
star
order
human
bacteri
bovin
canin
genom
read
match
genom
align
blast
inhous
viral
databas
contain
approxim
differ
viru
sequenc
sequenc
read
pass
qualiti
filter
blast
hit
lowest
e
valu
report
given
ident
higher
read
match
genom
use
clean
step
match
viral
genom
includ
databas
report
unknown
origin
optim
protocol
assess
compar
viru
amplicon
concentr
random
amplif
qpcr
evalu
fraction
read
differ
taxonom
categori
sequenc
count
absolut
number
read
fraction
total
qualiti
filter
read
individu
spike
viru
sequenc
experi
perform
duplic
triplic
statist
analysi
done
r
version
use
linear
model
coverag
plot
virus
use
spike
gener
map
viru
read
report
virmet
pipelin
smalt
http
default
threshold
follow
refer
genom
human
adenoviru
genbank
human
polioviru
mahoney
strain
first
three
differ
method
total
nucleic
acid
extract
test
qiaamp
viral
rna
mini
kit
purelink
viral
rnadna
mini
kit
autom
nuclisen
easymag
system
plasma
healthi
donor
spike
differ
virus
adenoviru
polioviru
influenzaviru
extract
concentr
eluat
determin
qpcr
easymag
extract
effici
rna
virus
viru
concentr
dna
virus
similar
purelink
extract
qiagen
extract
kit
led
lowest
recoveri
viral
genom
test
virus
addit
file
figur
tabl
thu
easymag
system
select
standard
extract
method
experi
order
assess
effect
sampl
prepar
sensit
metagenom
sequenc
spike
plasma
healthi
donor
rna
dna
virus
polioviru
adenoviru
virus
spike
qpcr
threshold
cycl
ct
valu
rang
differ
order
sampl
process
correspond
differ
preanalyt
situat
test
use
virusspik
plasma
condit
day
extract
compris
filtrat
extract
shortterm
storag
process
preprocess
compris
filtrat
storag
later
extract
archiv
sampl
compris
storag
filtrat
extract
three
condit
sampl
process
filter
well
nonfilt
condit
fraction
viru
read
significantli
increas
result
filtrat
day
extract
filtrat
extract
follow
freez
show
highest
enrich
viru
read
fig
consid
individu
virus
use
spike
three
virus
significantli
read
report
filter
sampl
number
fraction
total
read
pass
qualiti
filter
fig
c
addit
file
tabl
condit
preprocess
archiv
includ
freez
step
extract
prove
better
dna
virus
adenoviru
day
extract
note
condit
highest
number
spike
viru
read
report
polioviru
lowest
number
fig
c
although
ct
valu
input
viru
similar
sampl
chose
preprocess
standard
method
next
test
effect
nucleas
treatment
take
advantag
presenc
stabl
viru
capsid
protect
viral
genom
digest
metagenom
sequenc
plasma
spike
two
rna
virus
polioviru
influenzaviru
two
dna
virus
adenoviru
spike
plasma
incub
without
reaction
buffer
nucleas
serv
control
sampl
treat
nucleas
observ
increas
fraction
read
pass
qualiti
filter
fig
addit
file
tabl
result
digest
human
dna
contain
lot
repetit
low
entropi
sequenc
therefor
fewer
read
remov
qualiti
filter
nucleas
treatment
read
virus
increas
significantli
human
background
read
decreas
fig
freezethaw
cycl
improv
viru
enrich
nucleas
treatment
fig
consid
sequenc
read
individu
virus
nucleas
treatment
enrich
virus
except
larg
envelop
dna
viru
fig
addit
file
tabl
incub
alon
without
enrich
effect
nucleas
treatment
result
reduc
recoveri
rna
virus
influenza
polio
order
optim
unbias
amplif
nucleic
acid
repres
entir
viru
popul
sampl
divid
workflow
process
rna
dna
two
separ
reaction
chang
enzym
second
strand
synthesi
dna
polymeras
klenow
larg
fragment
comparison
sampl
volum
kept
ident
workflow
use
qpcr
random
pcr
amplif
higher
amplicon
concentr
obtain
dna
virus
process
separ
dna
workflow
compar
combin
protocol
data
shown
sequenc
fraction
viru
read
enrich
separ
protocol
dna
compar
combin
reaction
well
fig
importantli
higher
number
sequenc
read
obtain
virus
separ
workflow
compar
combin
workflow
especi
also
influenzaviru
fig
addit
file
tabl
shown
sampl
prepar
influenc
coverag
viral
genom
therefor
align
viru
read
report
combin
separ
workflow
viru
refer
genom
read
uniformli
distribut
along
refer
genom
workflow
addit
file
figur
test
higher
input
volum
revers
transcript
reaction
downstream
anchor
pcr
would
increas
viru
recoveri
use
separ
protocol
input
strategi
use
extract
revers
transcript
reaction
revers
transcript
reaction
anchor
pcr
input
strategi
use
doubl
amount
respect
viral
amplicon
concentr
anchor
pcr
higher
input
strategi
addit
file
figur
howev
fraction
viru
read
read
assign
spike
viru
similar
level
input
strategi
addit
file
figur
addit
file
tabl
final
workflow
depict
fig
establish
workflow
unbias
metagenom
sequenc
use
spike
plasma
sampl
use
new
protocol
test
highli
multiplex
viral
pathogen
reagent
nation
institut
biolog
standard
control
south
mimm
uk
contain
differ
human
virus
differ
viru
famili
tabl
process
sequenc
reagent
bioinformat
pipelin
virmet
determin
taxonom
origin
individu
read
sum
read
speci
level
note
commonli
report
strain
virus
expect
reagent
detect
differ
virus
two
replic
respect
high
number
read
tabl
previou
studi
sequenc
viral
pathogen
reagent
randomli
subsampl
raw
read
match
number
analyz
studi
use
read
still
detect
virus
one
replic
seven
eight
virus
detect
coronaviru
noroviru
gi
gii
influenzaviru
b
human
parainfluenza
viru
miss
method
well
compar
result
similar
workflow
filtrat
nucleas
treatment
random
amplif
nexteraxt
miseq
instanc
sampl
prepar
method
present
li
et
al
number
read
higher
report
identifi
viru
speci
tabl
read
previous
shown
addit
nontarget
virus
present
reagent
detect
us
well
eg
bovin
viral
diarrhea
viru
bocaviru
enteroviru
tabl
order
confirm
protocol
detect
virus
reproduc
quantit
manner
sequenc
plasma
sampl
spike
differ
ratio
concentr
rna
viru
polioviru
influenzaviru
dna
viru
adenoviru
first
spike
concentr
virus
spike
ten
time
ten
time
less
one
viru
keep
viru
constant
vice
versa
viru
extract
viral
amplicon
quantifi
eluat
ratio
spike
virus
perfectli
maintain
addit
file
figur
random
amplif
sequenc
separ
workflow
calcul
ratio
number
read
two
virus
number
total
read
sampl
vari
virus
amplifi
differenti
ratio
viru
read
sampl
correl
well
differ
ct
valu
initi
sampl
show
method
amplifi
detect
virus
reproduc
quantit
manner
fig
order
test
method
establish
plasma
also
work
clinic
sampl
spike
volum
plasma
urin
throat
swab
two
differ
stool
suspens
amount
virus
sequenc
fraction
viru
read
urin
throat
swab
similar
plasma
fig
addit
file
tabl
stool
sampl
howev
amount
unknown
background
read
substanti
higher
viru
read
detect
mostli
bacteriophag
individu
virus
spike
number
fraction
viru
read
significantli
decreas
stool
sampl
stringent
viru
enrich
protocol
therefor
need
sequenc
stool
sampl
achiev
sensit
studi
develop
valid
sampl
prepar
protocol
unbias
amplif
highthroughput
metagenom
sequenc
virus
routin
diagnost
use
unbias
metagenom
approach
prior
knowledg
viru
sequenc
requir
principl
therefor
detect
viru
howev
sampl
process
need
optim
recoveri
amplif
viral
genom
might
present
small
amount
clinic
sampl
optim
protocol
use
plasma
sampl
spike
differ
class
virus
first
test
filtrat
extract
nucleas
digest
procedur
order
find
optim
condit
viru
enrich
reduct
unwant
nonvir
read
filtrat
prove
indispens
number
viru
read
sequenc
significantli
increas
addit
sampl
preprocess
includ
freez
thaw
cycl
show
best
enrich
fig
best
integr
daili
laboratori
workflow
chose
preprocess
experi
two
extract
method
test
compar
higher
score
qiaamp
viral
rna
mini
kit
compar
purelink
viral
rnadna
mini
kit
studi
report
limit
coverag
genom
use
magnet
beadbas
method
similar
principl
easymag
howev
observ
obtain
good
coverag
entir
genom
addit
file
figur
nucleas
treatment
take
advantag
stabl
viru
capsid
shield
viral
genom
digest
significantli
reduc
fraction
human
read
increas
amount
read
pass
qualiti
filter
analysi
pipelin
result
digest
human
dna
contain
high
number
repetit
low
entropi
sequenc
import
maxim
amount
qualiti
read
increas
sensit
nucleas
treatment
enrich
virus
except
might
probabl
due
size
envelop
stabl
smaller
virus
combin
lowspe
centrifug
filtrat
nucleasetreat
also
show
greatest
increas
proport
viral
sequenc
studi
filtrat
dnase
treatment
lead
dramat
improv
studi
found
minor
differ
among
method
without
filtrat
nucleas
digest
reason
discrep
might
studi
compar
presequenc
nucleic
acid
concentr
other
compar
sequenc
read
enrich
method
gener
decreas
absolut
concentr
howev
hand
overal
gain
nucleas
treatment
increas
ratio
viru
host
prevail
polioviru
read
recov
highest
number
experi
although
amount
spike
virus
adjust
similar
level
ct
valu
might
due
fact
polioviru
smallest
virion
genom
size
among
spike
virus
might
facilit
effici
enrich
amplif
contrast
viru
larg
viru
respect
virion
genom
size
often
singl
read
could
detect
suggest
filtrat
might
actual
advers
effect
larg
viru
genom
herpesviru
mimiviru
studi
viru
profil
clinic
specimen
lower
number
read
expect
also
report
howev
experi
use
belong
viru
famili
result
mani
viru
read
therefor
conceiv
factor
viru
genom
size
influenc
number
recov
viral
genom
separ
random
amplif
two
separ
workflow
rna
dna
advantag
dna
virus
rna
virus
could
either
result
concomit
amplif
dna
virus
rna
workflow
indic
dna
genom
amplif
neg
affect
revers
transcript
second
strand
synthesi
previou
combin
workflow
yet
combin
separ
workflow
read
uniformli
distribut
across
refer
genom
observ
differ
order
valid
method
sequenc
multiplex
viral
pathogen
reagent
expect
contain
virus
across
differ
famili
genom
type
size
identifi
differ
virus
tabl
detect
read
eight
virus
suppos
reagent
singlestrand
rna
virus
coronaviru
noroviru
gi
gii
influenzaviru
b
metapneumoviru
human
parainfluenzaviru
howev
virus
present
low
concentr
viral
pathogen
reagent
undetect
qpcr
mix
reagent
also
frequent
detect
group
probe
reagent
studi
mee
et
al
wide
rang
differ
sampl
volum
enrich
amplif
sequenc
method
use
stochast
effect
detect
low
abund
virus
differ
analysi
threshold
could
play
role
well
compar
result
similar
workflow
filtrat
nucleas
treatment
random
amplif
nexteraxt
miseq
number
read
higher
report
identifi
viru
speci
therefor
think
method
might
still
potenti
improv
sensit
show
bia
certain
viru
famili
genom
type
eg
ssrna
assess
robust
sampl
prepar
correl
differ
ratio
spike
virus
number
correspond
sequenc
read
viru
combin
experi
perform
good
correl
ratio
spike
virus
ratio
result
read
fig
direct
correl
viral
copi
percentag
sequenc
read
suggest
howev
direct
quantif
input
copi
number
base
sequenc
read
seem
applic
virus
differ
properti
presenc
envelop
type
genom
virion
size
certain
viru
genom
type
amplifi
preferenti
seen
polioviru
experi
ad
complex
differ
composit
genet
background
clinic
sampl
strongli
influenc
yield
viru
read
nevertheless
correl
show
ratio
sequenc
read
preserv
differ
input
ratio
concentr
signifi
amplif
method
preserv
rel
contribut
differ
virus
sampl
final
spike
amount
virus
differ
sampl
show
protocol
present
could
appli
plasma
also
clinic
sampl
urin
swab
stringent
viru
enrich
protocol
need
sequenc
stool
sampl
biopsi
contain
lot
bacteri
human
background
read
respect
metagenom
viru
sequenc
protocol
present
allow
diagnost
laboratori
potenti
identifi
viru
present
clinic
sampl
singl
analysi
approach
reduc
time
cost
spent
today
multipl
test
perform
distinct
viru
allow
detect
rare
novel
virus
account
routin
test
panel
character
virom
alter
specif
diseas
set
might
help
better
understand
manag
infecti
diseas
final
analysi
highlight
need
valid
method
standard
metagenom
sequenc
approach
clinic
diagnost
